Physicians at CHOC lead a new study to improve survival rates of children with pediatric acute lymphoblastic leukemia (ALL).
Rare mitochondrial diseases are the focus of Feb. 10 virtual CureARS event
The upcoming webinar is open to the public, and will share the latest developments in the battle against rare mtARS mitochondrial diseases.
Leukemia stopped her in her tracks, but not her willingness to participate in oncology studies
A CHOC AYA oncology patient uses her experience to give back to others by participating in ongoing cancer research and clinical trials.
CHOC enrolls patient in international clinical trial to test anti-seizure medication in newborns
CHOC selects newborn patient as candidate for international study to test the efficacy of Lacosamide in the treatment of neonatal seizures.
CHOC Research Day 2022 highlights how computing and data science is assisting clinicians
CHOC’s Research Day 2022 focused on how computing and data science holds promising solutions to challenges in pediatric medicine.
Attacking pediatric brain tumors from both sides: An oncologist’s perspective
CHOC’s multidisciplinary team provides integrative molecular diagnosis and customized treatment plans for children with brain and spine tumors.
